Healthcare provider profile · identity verified

William Bensen, D.O.

Family Practice · SPENCER, IA · NPI 1750768339

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	558	112
Levothyroxine Sodium	Levothyroxine Sodium	551	89
Omeprazole	Omeprazole	447	68
Metoprolol Succinate	Metoprolol Succinate	388	87
Lisinopril	Lisinopril	387	76
Amlodipine Besylate	Amlodipine Besylate	371	69
Metformin Hcl Er	Metformin Hcl	371	74
Gabapentin	Gabapentin	338	50
Losartan Potassium	Losartan Potassium	282	60
Simvastatin	Simvastatin	278	51
Furosemide	Furosemide	255	54
Eliquis	Apixaban	251	40
Metoprolol Tartrate	Metoprolol Tartrate	236	32
Sertraline Hcl	Sertraline Hcl	210	33
Tamsulosin Hcl	Tamsulosin Hcl	185	35
Pantoprazole Sodium	Pantoprazole Sodium	143	30
Hydrochlorothiazide	Hydrochlorothiazide	141	24
Rosuvastatin Calcium	Rosuvastatin Calcium	140	39
Irbesartan	Irbesartan	130	23
Quetiapine Fumarate	Quetiapine Fumarate	129	suppressed
Alendronate Sodium	Alendronate Sodium	125	29
Famotidine	Famotidine	122	26
Potassium Chloride	Potassium Chloride	122	31
Clopidogrel	Clopidogrel Bisulfate	115	18
Buspirone Hcl	Buspirone Hcl	110	19
Montelukast Sodium	Montelukast Sodium	107	25
Tramadol Hcl	Tramadol Hcl	103	23
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	103	14
Venlafaxine Hcl Er	Venlafaxine Hcl	101	12
Mirtazapine	Mirtazapine	99	suppressed
Bupropion Xl	Bupropion Hcl	96	20
Fluticasone Propionate	Fluticasone Propionate	96	27
Glipizide	Glipizide	94	19
Duloxetine Hcl	Duloxetine Hcl	92	23
Allopurinol	Allopurinol	90	23
Trazodone Hcl	Trazodone Hcl	89	20
Atenolol	Atenolol	86	13
Lansoprazole	Lansoprazole	79	suppressed
Meloxicam	Meloxicam	79	13
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	78	14
Escitalopram Oxalate	Escitalopram Oxalate	77	18
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	72	suppressed
Klor-Con M10	Potassium Chloride	70	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	69	15
Jantoven	Warfarin Sodium	69	suppressed
Digoxin	Digoxin	65	suppressed
Pregabalin	Pregabalin	65	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	63	27
Memantine Hcl	Memantine Hcl	62	suppressed
Ozempic	Semaglutide	62	suppressed
Jardiance	Empagliflozin	61	12
Warfarin Sodium	Warfarin Sodium	60	14
Citalopram Hbr	Citalopram Hydrobromide	59	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	58	13
Bumetanide	Bumetanide	57	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	57	suppressed
Metformin Hcl	Metformin Hcl	56	14
Donepezil Hcl	Donepezil Hcl	55	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	13
Carvedilol	Carvedilol	50	13
Azelastine Hcl	Azelastine Hcl	49	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	48	12
Levetiracetam	Levetiracetam	48	suppressed
Xarelto	Rivaroxaban	46	suppressed
Benazepril Hcl	Benazepril Hcl	45	suppressed
Ropinirole Hcl	Ropinirole Hcl	45	suppressed
Finasteride	Finasteride	44	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	39	11
Ventolin Hfa	Albuterol Sulfate	39	suppressed
Klor-Con M20	Potassium Chloride	38	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	suppressed
Rybelsus	Semaglutide	34	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	34	suppressed
Colestipol Hcl	Colestipol Hcl	33	suppressed
Pravastatin Sodium	Pravastatin Sodium	33	12
Sulindac	Sulindac	33	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	32	suppressed
Lamotrigine	Lamotrigine	32	suppressed
Latanoprost	Latanoprost	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	31	suppressed
Cephalexin	Cephalexin	31	suppressed
Spironolactone	Spironolactone	31	11
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Lidocaine	Lidocaine	30	suppressed
Verapamil Er	Verapamil Hcl	30	suppressed
Topiramate	Topiramate	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Celecoxib	Celecoxib	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	28	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	28	suppressed
Aripiprazole	Aripiprazole	27	suppressed
Ipratropium Bromide	Ipratropium Bromide	27	suppressed
Baclofen	Baclofen	25	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	25	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	24	suppressed
Naproxen	Naproxen	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Ezetimibe	Ezetimibe	23	suppressed
Rivastigmine	Rivastigmine Tartrate	23	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	23	suppressed
Acyclovir	Acyclovir	22	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	22	suppressed
Propranolol Hcl Er	Propranolol Hcl	22	suppressed
Roflumilast	Roflumilast	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	21	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	suppressed
Naltrexone Hcl	Naltrexone Hcl	20	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Ondansetron Odt	Ondansetron	19	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Spiriva Respimat	Tiotropium Bromide	18	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	17	suppressed
Arnuity Ellipta	Fluticasone Furoate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Sotalol	Sotalol Hcl	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Diazepam	Diazepam	14	suppressed
Hydrocortisone	Hydrocortisone	14	13
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Ramelteon	Ramelteon	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Valsartan	Valsartan	14	suppressed
Cartia Xt	Diltiazem Hcl	13	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	12
Trulicity	Dulaglutide	13	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Lorazepam	Lorazepam	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error